Education, events and experts

Poster  -  14 April 2023

Differential immunomodulation following checkpoint blockade in the orthotopic ID8-luc ovarian model

Read Moreabout Differential immunomodulation following checkpoint blockade in the orthotopic ID8-luc ovarian model

Poster  -  14 April 2023

Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model

Read Moreabout Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model

Poster  -  14 April 2023

Transcriptional analysis of TME in MC38 colon carcinoma model following checkpoint inhibition

Read Moreabout Transcriptional analysis of TME in MC38 colon carcinoma model following checkpoint inhibition

Poster  -  14 April 2023

Fractionated dosing: A more clinically relevant approach to radiotherapy in preclinical tumor models

Read Moreabout Fractionated dosing: A more clinically relevant approach to radiotherapy in preclinical tumor models

Poster  -  14 April 2023

Growth kinetics and immune cell profiling of BT-474 human breast carcinoma and Raji-Luc human Burkitt's lymphoma in four strains of triple immunodeficient mice

Read Moreabout Growth kinetics and immune cell profiling of BT-474 human breast carcinoma and Raji-Luc human Burkitt's lymphoma in four strains of triple immunodeficient mice

Poster  -  13 September 2022

Spontaneous Neoplasms in the Uterus, Vagina and Cervix of Rats from 104-Week Carcinogenicity Studies

Read Moreabout Spontaneous Neoplasms in the Uterus, Vagina and Cervix of Rats from 104-Week Carcinogenicity Studies

Poster  -  13 September 2022

Spontaneous Neoplasms in the Uterus, Vagina and Cervix of Mice from Carcinogenicity Studies

Read Moreabout Spontaneous Neoplasms in the Uterus, Vagina and Cervix of Mice from Carcinogenicity Studies

Poster  -  12 September 2022

Comprehensive analysis of the association between RAS mutation and immune checkpoint marker expression

Read Moreabout Comprehensive analysis of the association between RAS mutation and immune checkpoint marker expression

Poster  -  16 May 2022

In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA

Read Moreabout In Vitro Characterization of CD19 CAR T Cells Derived by Electroporation of mRNA

Poster  -  16 May 2022

Development of an In Vitro Assay for Assessment of IL-2 Independent CAR T Proliferation

Read Moreabout Development of an In Vitro Assay for Assessment of IL-2 Independent CAR T Proliferation

Poster  -  8 April 2022

Comprehensive Cell- and Gene-Based Tumor Profiling Using Flow Cytometry and NanoString in a Murine Bladder Cancer Model

Read Moreabout Comprehensive Cell- and Gene-Based Tumor Profiling Using Flow Cytometry and NanoString in a Murine Bladder Cancer Model

Poster  -  8 April 2022

Systematic Evaluation of Cloudman S91 and YUMM1.7 Murine Melanoma Models to Immunotherapy and Focal Radiation

Read Moreabout Systematic Evaluation of Cloudman S91 and YUMM1.7 Murine Melanoma Models to Immunotherapy and Focal Radiation

Poster  -  8 April 2022

Model Characterization and Tumor Immune Profile Assessment for Syngeneic RM-1 Murine Prostate Cancer in Male C57BL/6 Mice

Read Moreabout Model Characterization and Tumor Immune Profile Assessment for Syngeneic RM-1 Murine Prostate Cancer in Male C57BL/6 Mice

Poster  -  8 April 2022

Reconstructed Plate-Based 3D Screening Assays That Predict In Vivo Responses

Read Moreabout Reconstructed Plate-Based 3D Screening Assays That Predict In Vivo Responses

Poster  -  8 April 2022

Chimeric Antigen Receptor (CAR) T Cell Generation for Therapeutic Testing in the Disseminated NALM6-Luc Human B-Cell Acute Lymphoblastic Leukemia Model

Read Moreabout Chimeric Antigen Receptor (CAR) T Cell Generation for Therapeutic Testing in the Disseminated NALM6-Luc Human B-Cell Acute Lymphoblastic Leukemia Model

Poster  -  7 December 2021

Combined Focal Radiation and Anti-mCTLA-4 Antibody Therapy Modulates Myeloid Subset Phospho-STAT3 Levels in the 4T1 Tumor Microenvironment, and Results in Tumor Growth Inhibition

Read Moreabout Combined Focal Radiation and Anti-mCTLA-4 Antibody Therapy Modulates Myeloid Subset Phospho-STAT3 Levels in the 4T1 Tumor Microenvironment, and Results in Tumor Growth Inhibition

Poster  -  10 November 2021

Cancer Testis Antigen Burden: A Novel Predictive Biomarker for Immunotherapy in Solid Tumors

Read Moreabout Cancer Testis Antigen Burden: A Novel Predictive Biomarker for Immunotherapy in Solid Tumors

Poster  -  10 November 2021

Prevalence of Secondary Immunotherapeutic Targets in the Absence of Established Immune Biomarkers in Solid Tumors

Read Moreabout Prevalence of Secondary Immunotherapeutic Targets in the Absence of Established Immune Biomarkers in Solid Tumors

Poster  -  10 November 2021

Novel Immunotherapeutic Targets in Cancer of Unknown Primary (CUP)

Read Moreabout Novel Immunotherapeutic Targets in Cancer of Unknown Primary (CUP)

Poster  -  22 June 2020

Anti-mPD-1 Reduces the Immuno-Suppressive Phenotype of Myeloid Subsets in the Murine Hepa 1-6 Tumor

Read Moreabout Anti-mPD-1 Reduces the Immuno-Suppressive Phenotype of Myeloid Subsets in the Murine Hepa 1-6 Tumor

Poster  -  22 June 2020

Immunophenotypic and Transcriptome Analyses of CT26 and 4T1-Luc Tumor Models Following Anti-mCTLA-4 Treatment

Read Moreabout Immunophenotypic and Transcriptome Analyses of CT26 and 4T1-Luc Tumor Models Following Anti-mCTLA-4 Treatment

Poster  -  22 June 2020

Combined Focal Radiation and Immune Checkpoint Inhibition Enhances Anti-Tumor Responses over Single Agent Treatment in a Murine Mammary Carcinoma Model

Read Moreabout Combined Focal Radiation and Immune Checkpoint Inhibition Enhances Anti-Tumor Responses over Single Agent Treatment in a Murine Mammary Carcinoma Model

Poster  -  22 June 2020

Targeted Radiation in Combination With Immunotherapy Agents in Murine Breast Cancer Models

Read Moreabout Targeted Radiation in Combination With Immunotherapy Agents in Murine Breast Cancer Models

Poster  -  22 June 2020

Gene Expression Profiling, Digital Spatial Profiling and Multiplex Immunohistochemistry of the Tumor-Immune Microenvironment in HNSCC Tumors

Read Moreabout Gene Expression Profiling, Digital Spatial Profiling and Multiplex Immunohistochemistry of the Tumor-Immune Microenvironment in HNSCC Tumors

Poster  -  22 June 2020

Characterization of the Orthotopic MMTV-PyMT Murine Mammary Carcinoma Model Following Radiation and Immune Checkpoint Blockade

Read Moreabout Characterization of the Orthotopic MMTV-PyMT Murine Mammary Carcinoma Model Following Radiation and Immune Checkpoint Blockade

Poster  -  22 June 2020

Development of a Robust MGMT Promoter Methylation Assay for Glioblastoma Multiforme

Read Moreabout Development of a Robust MGMT Promoter Methylation Assay for Glioblastoma Multiforme

Poster  -  4 October 2019

SelliahICCS19.pdf

Read Moreabout SelliahICCS19.pdf

Poster  -  13 April 2019

Systemic and Subcutaneous Modeling of A20 Murine B Cell Lymphoma in Mice: A Comparative Assessment

Read Moreabout Systemic and Subcutaneous Modeling of A20 Murine B Cell Lymphoma in Mice: A Comparative Assessment

Poster  -  10 April 2019

Radiation Response in Preclinical Orthotopic Models of Brain Cancer

Read Moreabout Radiation Response in Preclinical Orthotopic Models of Brain Cancer

Poster  -  3 April 2019

Preclinical Use of Focal Radiation and Immune Checkpoint Blockade to Improve Therapeutic Response in an Immunologically Cold Tumor

Read Moreabout Preclinical Use of Focal Radiation and Immune Checkpoint Blockade to Improve Therapeutic Response in an Immunologically Cold Tumor

Poster  -  3 April 2019

ID8-Luc Syngeneic Ovarian Cancer Model for Preclinical Evaluation of Immunomodulatory Molecules

Read Moreabout ID8-Luc Syngeneic Ovarian Cancer Model for Preclinical Evaluation of Immunomodulatory Molecules

Poster  -  18 April 2018

High-Throughput Analysis of MAPK and JAK-STAT Signaling in CT26 Tumors Using a Combination of Immunophenotyping and Phospho-Flow Cytometry

Read Moreabout High-Throughput Analysis of MAPK and JAK-STAT Signaling in CT26 Tumors Using a Combination of Immunophenotyping and Phospho-Flow Cytometry

Poster  -  18 April 2018

Evaluation of Immunomodulatory Agents in Classically Immunologically "Cold" Cancers Using Syngeneic Mouse Models of Breast and Ovarian Cancer

Read Moreabout Evaluation of Immunomodulatory Agents in Classically Immunologically "Cold" Cancers Using Syngeneic Mouse Models of Breast and Ovarian Cancer

Poster  -  18 April 2018

Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models

Read Moreabout Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models

Poster  -  14 April 2018

Unmasking T Cell Heterogeneity via Single Cell Transcriptomic Profiling

Read Moreabout Unmasking T Cell Heterogeneity via Single Cell Transcriptomic Profiling

Poster  -  30 October 2017

Sensitivity of Syngeneic Tumor Models to Focal Radiation

Read Moreabout Sensitivity of Syngeneic Tumor Models to Focal Radiation

Poster  -  9 May 2017

Preclinical Models of Multiple Myeloma

Read Moreabout Preclinical Models of Multiple Myeloma

Poster  -  5 April 2017

Focal Radiation Enhances Paclitaxel Therapy in a Mouse Model of Triple Negative Breast Cancer

Read Moreabout Focal Radiation Enhances Paclitaxel Therapy in a Mouse Model of Triple Negative Breast Cancer

Poster  -  5 April 2017

Image-Guided Focal Irradiation in Syngeneic Preclinical Oncology Mouse Models

Read Moreabout Image-Guided Focal Irradiation in Syngeneic Preclinical Oncology Mouse Models

Poster  -  20 April 2016

Preclinical Assessment of Anti-Tumor Activity and Immune Response in Syngeneic Tumor Models

Read Moreabout Preclinical Assessment of Anti-Tumor Activity and Immune Response in Syngeneic Tumor Models

Poster  -  20 April 2016

In-Depth Myeloid Cell Characterization in the Murine Syngeneic CT.26 Colon Carcinoma Model by 10-Color Flow Cytometry

Read Moreabout In-Depth Myeloid Cell Characterization in the Murine Syngeneic CT.26 Colon Carcinoma Model by 10-Color Flow Cytometry

Poster  -  8 November 2015

Preclinical Response of Murine Syngeneic Tumor Models to Immune Checkpoint Inhibitor Antibodies

Read Moreabout Preclinical Response of Murine Syngeneic Tumor Models to Immune Checkpoint Inhibitor Antibodies